E-selectin Antagonist GMI-1271 Shows a Favorable Safety, PK and Bleeding Profile in Phase I Studies of Healthy Volunteers of Medicine Division of Hematology Oncology, University of Michigan, Ann Arbor, MI;2Section of Vas - BJUI - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2016-12-12 15:21:52		E-selectin Antagonist GMI-1271 Shows a Favorable Safety, PK and Bleeding Profile in Phase I Studies of Healthy Volunteers of Medicine/Division of Hematology Oncology, University of Michigan, Ann Arbor, MI;2Section of Vas Add to Reading List Source URL: glycomimetics.com Download Document from Source Website File Size: 1,26 MB Share Document on Facebook